img

Global Exosome Therapeutics Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Exosome Therapeutics Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Exosome Therapeutics Market
Global Exosome Therapeutics market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Exosome Therapeutics industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Exosome Therapeutics key companies include Cellular Biomedicine Group, Codiak BioSciences, Coya Therapeutics, Curexsys, EV Therapeutics, Evox Therapeutics, ExoCoBio, ILIAS Biologics and Rion, etc. Cellular Biomedicine Group, Codiak BioSciences, Coya Therapeutics are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Exosome Therapeutics were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Exosome Therapeutics market and estimated to attract more attentions from industry insiders and investors.
Exosome Therapeutics can be divided into Monotherapy and Combination Therapy, etc. Monotherapy is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Exosome Therapeutics is widely used in various fields, such as Hospitals, Clinics & Ambulatory Centers, Cancer Research Institutes and Others, etc. Hospitals provides greatest supports to the Exosome Therapeutics industry development. In 2022, global % revenue of Exosome Therapeutics went into Hospitals filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Exosome Therapeutics market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Exosome Therapeutics market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Cellular Biomedicine Group
Codiak BioSciences
Coya Therapeutics
Curexsys
EV Therapeutics
Evox Therapeutics
ExoCoBio
ILIAS Biologics
Rion
SHIFTBIO
Segment by Type
Monotherapy
Combination Therapy

Segment by Application


Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Exosome Therapeutics introduction, etc. Exosome Therapeutics Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Exosome Therapeutics
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Exosome Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics & Ambulatory Centers
1.3.4 Cancer Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome Therapeutics Market Perspective (2018-2033)
2.2 Global Exosome Therapeutics Growth Trends by Region
2.2.1 Exosome Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Exosome Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Exosome Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Exosome Therapeutics Market Dynamics
2.3.1 Exosome Therapeutics Industry Trends
2.3.2 Exosome Therapeutics Market Drivers
2.3.3 Exosome Therapeutics Market Challenges
2.3.4 Exosome Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Exosome Therapeutics by Players
3.1.1 Global Exosome Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Exosome Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Exosome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Exosome Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Exosome Therapeutics Market Concentration Ratio
3.4.1 Global Exosome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Therapeutics Revenue in 2022
3.5 Global Key Players of Exosome Therapeutics Head office and Area Served
3.6 Global Key Players of Exosome Therapeutics, Product and Application
3.7 Global Key Players of Exosome Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Therapeutics Breakdown Data by Type
4.1 Global Exosome Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Exosome Therapeutics Forecasted Market Size by Type (2024-2033)
5 Exosome Therapeutics Breakdown Data by Application
5.1 Global Exosome Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Exosome Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Exosome Therapeutics Market Size (2018-2033)
6.2 North America Exosome Therapeutics Market Size by Type
6.2.1 North America Exosome Therapeutics Market Size by Type (2018-2023)
6.2.2 North America Exosome Therapeutics Market Size by Type (2024-2033)
6.2.3 North America Exosome Therapeutics Market Share by Type (2018-2033)
6.3 North America Exosome Therapeutics Market Size by Application
6.3.1 North America Exosome Therapeutics Market Size by Application (2018-2023)
6.3.2 North America Exosome Therapeutics Market Size by Application (2024-2033)
6.3.3 North America Exosome Therapeutics Market Share by Application (2018-2033)
6.4 North America Exosome Therapeutics Market Size by Country
6.4.1 North America Exosome Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Exosome Therapeutics Market Size by Country (2018-2023)
6.4.3 North America Exosome Therapeutics Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Exosome Therapeutics Market Size (2018-2033)
7.2 Europe Exosome Therapeutics Market Size by Type
7.2.1 Europe Exosome Therapeutics Market Size by Type (2018-2023)
7.2.2 Europe Exosome Therapeutics Market Size by Type (2024-2033)
7.2.3 Europe Exosome Therapeutics Market Share by Type (2018-2033)
7.3 Europe Exosome Therapeutics Market Size by Application
7.3.1 Europe Exosome Therapeutics Market Size by Application (2018-2023)
7.3.2 Europe Exosome Therapeutics Market Size by Application (2024-2033)
7.3.3 Europe Exosome Therapeutics Market Share by Application (2018-2033)
7.4 Europe Exosome Therapeutics Market Size by Country
7.4.1 Europe Exosome Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Exosome Therapeutics Market Size by Country (2018-2023)
7.4.3 Europe Exosome Therapeutics Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Exosome Therapeutics Market Size (2018-2033)
8.2 China Exosome Therapeutics Market Size by Type
8.2.1 China Exosome Therapeutics Market Size by Type (2018-2023)
8.2.2 China Exosome Therapeutics Market Size by Type (2024-2033)
8.2.3 China Exosome Therapeutics Market Share by Type (2018-2033)
8.3 China Exosome Therapeutics Market Size by Application
8.3.1 China Exosome Therapeutics Market Size by Application (2018-2023)
8.3.2 China Exosome Therapeutics Market Size by Application (2024-2033)
8.3.3 China Exosome Therapeutics Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Exosome Therapeutics Market Size (2018-2033)
9.2 Asia Exosome Therapeutics Market Size by Type
9.2.1 Asia Exosome Therapeutics Market Size by Type (2018-2023)
9.2.2 Asia Exosome Therapeutics Market Size by Type (2024-2033)
9.2.3 Asia Exosome Therapeutics Market Share by Type (2018-2033)
9.3 Asia Exosome Therapeutics Market Size by Application
9.3.1 Asia Exosome Therapeutics Market Size by Application (2018-2023)
9.3.2 Asia Exosome Therapeutics Market Size by Application (2024-2033)
9.3.3 Asia Exosome Therapeutics Market Share by Application (2018-2033)
9.4 Asia Exosome Therapeutics Market Size by Region
9.4.1 Asia Exosome Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Exosome Therapeutics Market Size by Region (2018-2023)
9.4.3 Asia Exosome Therapeutics Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Exosome Therapeutics Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Exosome Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Exosome Therapeutics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Exosome Therapeutics Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Exosome Therapeutics Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Exosome Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Exosome Therapeutics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Exosome Therapeutics Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Exosome Therapeutics Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Exosome Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Exosome Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Exosome Therapeutics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Exosome Therapeutics Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Cellular Biomedicine Group
11.1.1 Cellular Biomedicine Group Company Details
11.1.2 Cellular Biomedicine Group Business Overview
11.1.3 Cellular Biomedicine Group Exosome Therapeutics Introduction
11.1.4 Cellular Biomedicine Group Revenue in Exosome Therapeutics Business (2018-2023)
11.1.5 Cellular Biomedicine Group Recent Developments
11.2 Codiak BioSciences
11.2.1 Codiak BioSciences Company Details
11.2.2 Codiak BioSciences Business Overview
11.2.3 Codiak BioSciences Exosome Therapeutics Introduction
11.2.4 Codiak BioSciences Revenue in Exosome Therapeutics Business (2018-2023)
11.2.5 Codiak BioSciences Recent Developments
11.3 Coya Therapeutics
11.3.1 Coya Therapeutics Company Details
11.3.2 Coya Therapeutics Business Overview
11.3.3 Coya Therapeutics Exosome Therapeutics Introduction
11.3.4 Coya Therapeutics Revenue in Exosome Therapeutics Business (2018-2023)
11.3.5 Coya Therapeutics Recent Developments
11.4 Curexsys
11.4.1 Curexsys Company Details
11.4.2 Curexsys Business Overview
11.4.3 Curexsys Exosome Therapeutics Introduction
11.4.4 Curexsys Revenue in Exosome Therapeutics Business (2018-2023)
11.4.5 Curexsys Recent Developments
11.5 EV Therapeutics
11.5.1 EV Therapeutics Company Details
11.5.2 EV Therapeutics Business Overview
11.5.3 EV Therapeutics Exosome Therapeutics Introduction
11.5.4 EV Therapeutics Revenue in Exosome Therapeutics Business (2018-2023)
11.5.5 EV Therapeutics Recent Developments
11.6 Evox Therapeutics
11.6.1 Evox Therapeutics Company Details
11.6.2 Evox Therapeutics Business Overview
11.6.3 Evox Therapeutics Exosome Therapeutics Introduction
11.6.4 Evox Therapeutics Revenue in Exosome Therapeutics Business (2018-2023)
11.6.5 Evox Therapeutics Recent Developments
11.7 ExoCoBio
11.7.1 ExoCoBio Company Details
11.7.2 ExoCoBio Business Overview
11.7.3 ExoCoBio Exosome Therapeutics Introduction
11.7.4 ExoCoBio Revenue in Exosome Therapeutics Business (2018-2023)
11.7.5 ExoCoBio Recent Developments
11.8 ILIAS Biologics
11.8.1 ILIAS Biologics Company Details
11.8.2 ILIAS Biologics Business Overview
11.8.3 ILIAS Biologics Exosome Therapeutics Introduction
11.8.4 ILIAS Biologics Revenue in Exosome Therapeutics Business (2018-2023)
11.8.5 ILIAS Biologics Recent Developments
11.9 Rion
11.9.1 Rion Company Details
11.9.2 Rion Business Overview
11.9.3 Rion Exosome Therapeutics Introduction
11.9.4 Rion Revenue in Exosome Therapeutics Business (2018-2023)
11.9.5 Rion Recent Developments
11.10 SHIFTBIO
11.10.1 SHIFTBIO Company Details
11.10.2 SHIFTBIO Business Overview
11.10.3 SHIFTBIO Exosome Therapeutics Introduction
11.10.4 SHIFTBIO Revenue in Exosome Therapeutics Business (2018-2023)
11.10.5 SHIFTBIO Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Exosome Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global Exosome Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Exosome Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Exosome Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Exosome Therapeutics Market Share by Region (2018-2023)
Table 8. Global Exosome Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Exosome Therapeutics Market Share by Region (2024-2033)
Table 10. Exosome Therapeutics Market Trends
Table 11. Exosome Therapeutics Market Drivers
Table 12. Exosome Therapeutics Market Challenges
Table 13. Exosome Therapeutics Market Restraints
Table 14. Global Exosome Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Exosome Therapeutics Revenue Share by Players (2018-2023)
Table 16. Global Top Exosome Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapeutics as of 2022)
Table 17. Global Exosome Therapeutics Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Exosome Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Exosome Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Exosome Therapeutics, Product and Application
Table 21. Global Key Players of Exosome Therapeutics, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Exosome Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Exosome Therapeutics Revenue Market Share by Type (2018-2023)
Table 25. Global Exosome Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Exosome Therapeutics Revenue Market Share by Type (2024-2033)
Table 27. Global Exosome Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Exosome Therapeutics Revenue Share by Application (2018-2023)
Table 29. Global Exosome Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Exosome Therapeutics Revenue Share by Application (2024-2033)
Table 31. North America Exosome Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Exosome Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Exosome Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Exosome Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Exosome Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Exosome Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Exosome Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Exosome Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Exosome Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Exosome Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Exosome Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Exosome Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Exosome Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Exosome Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Exosome Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Exosome Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Exosome Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Exosome Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Exosome Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Exosome Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Exosome Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Exosome Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Exosome Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Exosome Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Exosome Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Exosome Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Exosome Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Exosome Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Exosome Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Exosome Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Exosome Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Exosome Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 63. Cellular Biomedicine Group Company Details
Table 64. Cellular Biomedicine Group Business Overview
Table 65. Cellular Biomedicine Group Exosome Therapeutics Product
Table 66. Cellular Biomedicine Group Revenue in Exosome Therapeutics Business (2018-2023) & (US$ Million)
Table 67. Cellular Biomedicine Group Recent Developments
Table 68. Codiak BioSciences Company Details
Table 69. Codiak BioSciences Business Overview
Table 70. Codiak BioSciences Exosome Therapeutics Product
Table 71. Codiak BioSciences Revenue in Exosome Therapeutics Business (2018-2023) & (US$ Million)
Table 72. Codiak BioSciences Recent Developments
Table 73. Coya Therapeutics Company Details
Table 74. Coya Therapeutics Business Overview
Table 75. Coya Therapeutics Exosome Therapeutics Product
Table 76. Coya Therapeutics Revenue in Exosome Therapeutics Business (2018-2023) & (US$ Million)
Table 77. Coya Therapeutics Recent Developments
Table 78. Curexsys Company Details
Table 79. Curexsys Business Overview
Table 80. Curexsys Exosome Therapeutics Product
Table 81. Curexsys Revenue in Exosome Therapeutics Business (2018-2023) & (US$ Million)
Table 82. Curexsys Recent Developments
Table 83. EV Therapeutics Company Details
Table 84. EV Therapeutics Business Overview
Table 85. EV Therapeutics Exosome Therapeutics Product
Table 86. EV Therapeutics Revenue in Exosome Therapeutics Business (2018-2023) & (US$ Million)
Table 87. EV Therapeutics Recent Developments
Table 88. Evox Therapeutics Company Details
Table 89. Evox Therapeutics Business Overview
Table 90. Evox Therapeutics Exosome Therapeutics Product
Table 91. Evox Therapeutics Revenue in Exosome Therapeutics Business (2018-2023) & (US$ Million)
Table 92. Evox Therapeutics Recent Developments
Table 93. ExoCoBio Company Details
Table 94. ExoCoBio Business Overview
Table 95. ExoCoBio Exosome Therapeutics Product
Table 96. ExoCoBio Revenue in Exosome Therapeutics Business (2018-2023) & (US$ Million)
Table 97. ExoCoBio Recent Developments
Table 98. ILIAS Biologics Company Details
Table 99. ILIAS Biologics Business Overview
Table 100. ILIAS Biologics Exosome Therapeutics Product
Table 101. ILIAS Biologics Revenue in Exosome Therapeutics Business (2018-2023) & (US$ Million)
Table 102. ILIAS Biologics Recent Developments
Table 103. Rion Company Details
Table 104. Rion Business Overview
Table 105. Rion Exosome Therapeutics Product
Table 106. Rion Revenue in Exosome Therapeutics Business (2018-2023) & (US$ Million)
Table 107. Rion Recent Developments
Table 108. SHIFTBIO Company Details
Table 109. SHIFTBIO Business Overview
Table 110. SHIFTBIO Exosome Therapeutics Product
Table 111. SHIFTBIO Revenue in Exosome Therapeutics Business (2018-2023) & (US$ Million)
Table 112. SHIFTBIO Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Exosome Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Exosome Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Monotherapy Features
Figure 4. Combination Therapy Features
Figure 5. Global Exosome Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Exosome Therapeutics Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Clinics & Ambulatory Centers Case Studies
Figure 9. Cancer Research Institutes Case Studies
Figure 10. Others Case Studies
Figure 11. Exosome Therapeutics Report Years Considered
Figure 12. Global Exosome Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Exosome Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Exosome Therapeutics Market Share by Region: 2022 VS 2033
Figure 15. Global Exosome Therapeutics Market Share by Players in 2022
Figure 16. Global Top Exosome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapeutics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Exosome Therapeutics Revenue in 2022
Figure 18. North America Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Exosome Therapeutics Market Share by Type (2018-2033)
Figure 20. North America Exosome Therapeutics Market Share by Application (2018-2033)
Figure 21. North America Exosome Therapeutics Market Share by Country (2018-2033)
Figure 22. United States Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Exosome Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Exosome Therapeutics Market Share by Type (2018-2033)
Figure 26. Europe Exosome Therapeutics Market Share by Application (2018-2033)
Figure 27. Europe Exosome Therapeutics Market Share by Country (2018-2033)
Figure 28. Germany Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Exosome Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Exosome Therapeutics Market Share by Type (2018-2033)
Figure 36. China Exosome Therapeutics Market Share by Application (2018-2033)
Figure 37. Asia Exosome Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Exosome Therapeutics Market Share by Type (2018-2033)
Figure 39. Asia Exosome Therapeutics Market Share by Application (2018-2033)
Figure 40. Asia Exosome Therapeutics Market Share by Region (2018-2033)
Figure 41. Japan Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Exosome Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Exosome Therapeutics Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Exosome Therapeutics Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Exosome Therapeutics Market Share by Country (2018-2033)
Figure 51. Brazil Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Exosome Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Cellular Biomedicine Group Revenue Growth Rate in Exosome Therapeutics Business (2018-2023)
Figure 58. Codiak BioSciences Revenue Growth Rate in Exosome Therapeutics Business (2018-2023)
Figure 59. Coya Therapeutics Revenue Growth Rate in Exosome Therapeutics Business (2018-2023)
Figure 60. Curexsys Revenue Growth Rate in Exosome Therapeutics Business (2018-2023)
Figure 61. EV Therapeutics Revenue Growth Rate in Exosome Therapeutics Business (2018-2023)
Figure 62. Evox Therapeutics Revenue Growth Rate in Exosome Therapeutics Business (2018-2023)
Figure 63. ExoCoBio Revenue Growth Rate in Exosome Therapeutics Business (2018-2023)
Figure 64. ILIAS Biologics Revenue Growth Rate in Exosome Therapeutics Business (2018-2023)
Figure 65. Rion Revenue Growth Rate in Exosome Therapeutics Business (2018-2023)
Figure 66. SHIFTBIO Revenue Growth Rate in Exosome Therapeutics Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries